89bio
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $21 | $0 |
Gross Profit | -8 | -10 | 21 | -8 |
EBITDA | -115,824 | -75,909 | -116,897 | -146,499 |
EBIT | -115,832 | -72,405 | -116,906 | -146,507 |
Net Income | -111,504 | -71,275 | -118,354 | -149,073 |
Net Change In Cash | 0 | 0 | 21 | 0 |
Free Cash Flow | -100,425 | -71,809 | -121,595 | -145,359 |
Cash | 129,076 | 315,396 | 126,060 | 91,411 |
Basic Shares | 157,880 | 115,955 | 115,955 | 107,075 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -38 | -273 | -240 | -79 |
EBITDA | -384,656 | -134,463 | -99,845 | -89,664 |
EBIT | -371,677 | -134,736 | -100,085 | -89,743 |
Net Income | -367,079 | -142,189 | -102,026 | -90,122 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 2,798 | |||
Free Cash Flow | -367,838 | -129,190 | -81,097 | -76,844 |
Cash | 126,060 | 316,161 | 55,255 | 52,432 |
Basic Shares | 104,714 | 71,172 | 34,806 | 20,098 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.71 |
2025-03-31 | -$0.49 |
2024-12-31 | -$1.02 |
